@gonzalogoy's peptide claims need more evidence

What does this video actually claim?

Gonzalo Goy posts about peptides including MOTS-c, TB-500, and KPV, sharing his personal experiences with these compounds for bodybuilding purposes. The video focuses on subjective results rather than making specific medical claims.

The hashtags suggest he's discussing these peptides in the context of muscle building and recovery. Without access to the full video content, we're working with limited information about his specific claims.

What does the current research actually show?

The peptides he mentions have varying levels of scientific support. TB-500, a synthetic version of thymosin beta-4, showed wound healing benefits in a small 2012 study by Ruff et al. in the Annals of the New York Academy of Sciences, but human data remains limited.

MOTS-c research is even more preliminary. Lee et al. (2015) published mouse studies in Cell Metabolism showing metabolic benefits, but human trials are scarce. KPV, an anti-inflammatory tripeptide, has shown promise in inflammatory bowel disease models (Kannengiesser et al., 2008), but clinical applications aren't established.

The bodybuilding community has embraced these compounds faster than the research can validate their safety or effectiveness in healthy individuals.

What are the regulatory concerns?

None of these peptides have FDA approval for the uses Goy discusses. TB-500 is prohibited by the World Anti-Doping Agency for competitive athletes. The FDA has issued warning letters to companies selling these compounds as supplements.

Many peptides sold online aren't pharmaceutical grade. A 2021 analysis by Dunne et al. in the Journal of Clinical Medicine found significant quality control issues with research peptides sold to consumers.

Personal experiences don't constitute clinical evidence. What works for one person may not work for others, and individual responses can vary dramatically.

What should you know about peptide therapy?

Legitimate peptide therapy exists through licensed healthcare providers. Some peptides like semaglutide and tesamorelin have clear FDA approvals for specific conditions with established dosing protocols.

The compounds Goy discusses fall into a gray area where research is ongoing but clinical applications aren't proven. If you're interested in peptide therapy, work with a qualified healthcare provider who can assess your individual situation.

Social media testimonials, even from well-meaning fitness influencers, shouldn't replace medical guidance. The long-term effects of many research peptides in healthy individuals simply aren't known.